Butterly, Elaine, Wei, L, Adler, Amanda I et al. (16 more authors) (2022) Calibrating a network meta-analysis of diabetes trials of sodium glucose co-transporter 2 inhibitors, glucagon-like peptide-1 receptor analogues and dipeptidyl peptidase-4 inhibitors to a representative routine population:a systematic review protocol. BMJ Open. e066491. ISSN 2044-6055
Metadata
Item Type: | Article |
---|---|
Authors/Creators: |
|
Copyright, Publisher and Additional Information: | © Author(s) (or their employer(s)) 2022 |
Dates: |
|
Institution: | The University of York |
Academic Units: | The University of York > Faculty of Social Sciences (York) > Centre for Reviews and Dissemination (York) |
Funding Information: | Funder Grant number MEDICAL RESEARCH COUNCIL (MRC) MR/T017112/1 |
Depositing User: | Pure (York) |
Date Deposited: | 06 Oct 2022 13:00 |
Last Modified: | 16 Oct 2024 18:46 |
Published Version: | https://doi.org/10.1136/bmjopen-2022-066491 |
Status: | Published |
Refereed: | Yes |
Identification Number: | 10.1136/bmjopen-2022-066491 |
Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:191578 |
Download
Filename: e066491.full.pdf
Description: Calibrating a network meta-analysis of diabetes trials of sodium glucose cotransporter 2 inhibitors, glucagon-like peptide-1 receptor analogues and dipeptidyl peptidase-4 inhibitors to a representative routine population: a systematic review protocol
Licence: CC-BY 2.5